The company is transitioning from a small-scale trader of solar modules and renewable energy equipment into an integrated agricultural and food processing group focused on sourcing, processing, and exporting commodities like peanuts and pulses.
The company operates as a commodity trading intermediary with no proprietary brands, unique technology, or scale advantages, as evidenced by razor-thin net margins of 0.3% and a lack of fixed assets. The proposed pivot into food processing introduces manufacturing capability, but current financials reflect a pure commodity business with no pricing power.
Historically passive, the company recently underwent a massive capital event where warrant conversions by the promoter group increased net worth 36-fold. Most of this fresh capital was immediately deployed into advances to legacy solar-sector suppliers rather than the stated agricultural pivot, raising questions about the speed and focus of deployment.
The investment collapsed when the massive capital infusion from the promoter group, which was ostensibly for an agricultural pivot, remained permanently trapped in unsecured advances to solar-sector suppliers. The business failed to transition into a value-added food processor, remaining a low-margin commodity intermediary until the concentrated credit risk materialized as a total write-off of the advances. With the board in constant flux and no operational scale, the company's cash was drained by working capital inefficiencies and related-party entanglements, leaving shareholders with a hollow shell.
RichFakir rates FRESITA PROTEINS LIMITED's business quality as poor — 31/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, FRESITA PROTEINS LIMITED is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on FRESITA PROTEINS LIMITED is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of FRESITA PROTEINS LIMITED's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →